TGFB1 and COVID-19: In the study by Basheer et al., a diverse array of cytokines, including TGF-β and IL-10, were linked to both mortality and severe lung involvement in COVID-19 patients, underscoring the complex interplay between inflammatory responses and clinical outcomes [31].